N.H. (November 6, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader
providing innovative cancer detection and therapy solutions, today announced that it will
release financial results for the third quarter and nine months ended September
30, 2018 after the close of the market and host a conference call at 4:30pm
Eastern Time on Tuesday, November 13th.
13th @ 4:30 pm Eastern Time
Conference ID: 1529049
available through November 27th:
addition, a replay of the call will remain on the Company’s website (www.icadmed.com)
until the Company releases its fourth quarter and year ended 2018 financial
About iCAD, Inc.
Headquartered in Nashua, NH,
iCAD is a global medical technology leader providing innovative cancer
detection and therapy solutions. For more information, visit www.icadmed.com.
on behalf of iCAD, Inc.